Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models

Ferlay, 2019, Estimating the globalcancer incidence and mortality in 2018: GLOBOCAN sources and methods, Int. J. Cancer, 144, 1941, 10.1002/ijc.31937 Bruix, 2015, Liver cancer: approaching a personalized care, J. Hepatol., 62, S144, 10.1016/j.jhep.2015.02.007 Niu, 2017, New insights into sorafenib resistance in hepatocellular carcinoma: responsible mechanisms and promising strategies, Biochim. Biophys. Acta Rev. Cancer, 1868, 564, 10.1016/j.bbcan.2017.10.002 Xie, 2020, Comprehensive review of targeted therapy for colorectal cancer, Signal Transduct. Target. Ther., 5, 22, 10.1038/s41392-020-0116-z Sala-Valdes, 2012, Targeting tetraspanins in cancer, Expert Opin. Ther. Targets, 16, 985, 10.1517/14728222.2012.712688 Muller-Pillasch, 1998, Identification of a new tumour-associated antigen TM4SF5 and its expression in human cancer, Gene, 208, 25, 10.1016/S0378-1119(97)00633-1 Lee, 2008, Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma, J. Clin. Invest., 118, 1354, 10.1172/JCI33768 Wu, 2013, A high level of TM4SF5 is associated with human esophageal cancer progression and poor patient survival, Dig. Dis. Sci., 58, 2623, 10.1007/s10620-013-2690-1 Choi, 2009, Cooperation between integrin alpha5 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity, Blood, 113, 1845, 10.1182/blood-2008-05-160671 Lee, 2015, Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells, Hepatology, 61, 1978, 10.1002/hep.27721 Lee, 2012, Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial-mesenchymal transition, Biochim. Biophys. Acta, 1823, 514, 10.1016/j.bbamcr.2011.11.017 Lee, 2009, The extracellular loop 2 of TM4SF5 inhibits integrin alpha2 on hepatocytes under collagen type I environment, Carcinogenesis, 30, 1872, 10.1093/carcin/bgp234 Lee, 2009, Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative, Hepatology, 49, 1316, 10.1002/hep.22777 Ahn, 2017, Anti-cancer activity of novel TM4SF5-targeting antibodies through TM4SF5 neutralization and immune cell-mediated cytotoxicity, Theranostics, 7, 594, 10.7150/thno.15629 Holliger, 2005, Engineered antibody fragments and the rise of single domains, Nat. Biotechnol., 23, 1126, 10.1038/nbt1142 Subramaniam, 2013, Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma, Biochim. Biophys. Acta, 1835, 46 Shimizu, 1996, Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL, Cancer Res., 56, 2161 Safdari, 2013, Antibody humanization methods - a review and update, Biotechnol. Genet. Eng. Rev., 29, 175, 10.1080/02648725.2013.801235 Ahmadzadeh, 2014, Antibody humanization methods for development of therapeutic applications, Monoclon. Antib. Immunodiagn. Immunother., 33, 67, 10.1089/mab.2013.0080 Ryu, 2021, Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression, J. Pathol., 253, 55, 10.1002/path.5548 Xia, 2020, The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma, EBioMedicine, 51, 102610, 10.1016/j.ebiom.2019.102610 Lee, 2011, Differential inhibition of transmembrane 4 L six family member 5 (TM4SF5)-mediated tumorigenesis by TSAHC and sorafenib, Cancer Biol. Ther., 11, 330, 10.4161/cbt.11.3.14099 Tai, 2011, Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma, J. Hepatol., 55, 1041, 10.1016/j.jhep.2011.01.047 Su, 2014, SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinoma, Neoplasia, 16, 595, 10.1016/j.neo.2014.06.005 Zhao, 2020, Berbamine (BBM), a natural STAT3 inhibitor, synergistically enhances the antigrowth and proapoptotic effects of sorafenib on hepatocellular carcinoma cells, ACS Omega, 5, 24838, 10.1021/acsomega.0c03527 Byeon, 2019, Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer, Exp. Mol. Med., 51, 1, 10.1038/s12276-018-0202-2 Kim, 2014, Membrane proteins involved in epithelial-mesenchymal transition and tumor invasion: studies on TMPRSS4 and TM4SF5, Genomics Inform, 12, 12, 10.5808/GI.2014.12.1.12 Tsuchikama, 2018, Antibody-drug conjugates: recent advances in conjugation and linker chemistries, Protein Cell, 9, 33, 10.1007/s13238-016-0323-0 June, 2018, CAR T cell immunotherapy for human cancer, Science, 359, 1361, 10.1126/science.aar6711 Pettitt, 2018, CAR-T cells: a systematic review and mixed methods analysis of the clinical trial landscape, Mol. Ther., 26, 342, 10.1016/j.ymthe.2017.10.019 Jung, 2006, E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis, Nat. Med., 12, 809, 10.1038/nm1440 Lee, 2021, TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1, J. Exp. Clin. Cancer Res., 40, 372, 10.1186/s13046-021-02147-7 Lee, 2021, TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activity, J. Exp. Clin. Cancer Res., 40, 58, 10.1186/s13046-021-01828-7 Yang, 2009, Construction of a large synthetic human scFv library with six diversified CDRs and high functional diversity, Mol. Cells, 27, 225, 10.1007/s10059-009-0028-9 Zhang, 2017, Humanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: rationale and examples, MAbs, 9, 419, 10.1080/19420862.2017.1289302 Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci. Signal., 6, pl1, 10.1126/scisignal.2004088 Cerami, 2012, The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov., 2, 401, 10.1158/2159-8290.CD-12-0095